Jury Awards Man $3M for Defective Airbag That Caused Serious Injury in Crash
A South Florida jury has awarded $3 million to a man who was severely injured by a defective airbag in a 2020 crash.
Miami-Dade jurors reached a verdict for Jose Hernandez on Thursday, according to court records. He had filed a lawsuit in 2022 against Takata Airbag Tort Compensation Trust Fund, which was formed during Takata’s bankruptcy.
Related: Italy Court Allows Class Action Against Stellantis Over Faulty Airbags
Hernandez was driving his 2005 Honda Civic in Miami in December 2020 when another vehicle hit him as he tried to make a left turn, his attorneys said. The collision should have caused only minor injuries, but the car’s Takata airbag inflator improperly exploded, shooting a piece of metal shrapnel several inches long into Hernandez’s right arm, the lawsuit said.
Attorneys for the Takata trust didn’t immediately respond to an email Monday seeking comment.
Related: US Backs Off Effort to Recall About 50 Million Air Bag Parts
At least 28 deaths have been linked to Takata air bag inflators in the U.S. and at least 36 worldwide, according to regulators. More than 400 people in the U.S. have been hurt. Large-scale recalls began in 2013.
Takata used ammonium nitrate to create a small explosion to inflate air bags in a crash. But the chemical can deteriorate over time due to high heat and humidity and explode with too much force. That can blow apart a metal canister and send shrapnel into the passenger compartment.
- Agentic Intelligence for Claims Dominates New Tech Launches
- HSBC Executive Strikes Back in Court Fight Over Poaching Claims
- Golden Gate Sued Over Insurer’s $2.2 Billion Capital Shortfall
- Before the Nuclear Verdict: Rethinking How Liability Claims Are Managed
- Credit Acceptance Reaches $710M Predatory Auto Lending Settlement With Most States
- The Nation’s Insurance Laboratory: What Liability Trends in California Mean for the Rest of the Country
- Are We Training Claims Adjusters or Claims Processors?
- The Great Hemp Reset: How the Federal Ban on Intoxicating Hemp Products Will Reshape Risk and Coverage